Veradermics, Incorporated
MANE
$99.69
-$4.14-3.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 819.89M | 390.80M | 141.86M | -- | |
| Total Receivables | 1.59M | 1.65M | 1.26M | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 2.13M | 4.02M | 5.61M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 1.14M | 602.00K | 3.77M | -- | |
| Total Current Assets | 824.75M | 397.07M | 152.49M | -- | |
|
|
|||||
| Total Current Assets | 824.75M | 397.07M | 152.49M | -- | |
| Net Property, Plant & Equipment | 989.00K | 287.00K | 125.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 825.74M | 397.36M | 152.62M | -- | |
|
|
|||||
| Total Accounts Payable | 5.92M | 1.07M | 2.13M | -- | |
| Total Accrued Expenses | 5.40M | 5.61M | 6.98M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 379.00K | 39.00K | 47.00K | -- | |
| Total Other Current Liabilities | 379.00K | 39.00K | 47.00K | -- | |
| Total Current Liabilities | 11.69M | 6.72M | 9.15M | -- | |
|
|
|||||
| Total Current Liabilities | 11.69M | 6.72M | 9.15M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 428.00K | -- | 4.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 12.12M | 6.72M | 9.16M | -- | |
|
|
|||||
| Common Stock & APIC | 989.26M | 543.05M | 2.35M | -- | |
| Retained Earnings | -174.16M | -150.65M | -123.42M | -- | |
| Treasury Stock & Other | -1.49M | -1.75M | -1.79M | -- | |
| Total Common Equity | 813.61M | 390.64M | -122.86M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 266.33M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 266.33M | -- | |
|
|
|||||
| Total Common Equity | 813.61M | 390.64M | -122.86M | -- | |
| Total Preferred Equity | -- | -- | 266.33M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 813.61M | 390.64M | 143.46M | -- | |
|
|
|||||